Closed · HT9425-23-NFRP-IIRA · CFDA 12.420 · Discretionary
DoD Neurofibromatosis Investigator-Initiated Award
Federal grant opportunity posted by Dept. of the Army -- USAMRAA, cataloged on Grants.gov.
- Varies
- Award range
- Closed
- Status
- October 5, 2023
- Close date
- 5
- Expected awards
The verdict
DoD Neurofibromatosis Investigator-Initiated Award is a closed discretionary listing from Dept. of the Army -- USAMRAA that offered Varies by applicant across 5 expected awards. Future funding cycles may be published under the same CFDA number.
- Varies
- award range
- Closed
- application status
- 5
- expected awards
- 12.420
- CFDA program
Opportunity snapshot. This Grants.gov announcement - DoD Neurofibromatosis Investigator-Initiated Award - is cataloged under number HT9425-23-NFRP-IIRA and tied to CFDA assistance listing 12.420, posted by Dept. of the Army -- USAMRAA. Grants.gov currently shows the opportunity as closed, first posted on May 22, 2023 and last updated on August 10, 2023. The funding category is Discretionary, delivered as a grant.
Award economics. The award range on file is Varies by applicant. The agency has projected $4.4 million in total estimated funding for this announcement. It expects to issue 5 awards. If the agency funds the expected 5 awards from the $4.4 million estimated pool, the average award works out to roughly $888,000. Cost sharing is not required, so applicants do not need to commit matching funds to be competitive on this opportunity. Federal award ranges are often upper bounds; actual allocations reflect program appropriations, the strength of the applicant pool, and the evaluation committee's scoring.
Deadline and action path. This opportunity closed on October 5, 2023. Future funding cycles may be published under the same CFDA number, so monitoring the parent program page is the most reliable way to catch re-announcements. Every Grants.gov submission requires an active SAM.gov registration and a Unique Entity ID. Review the Eligibility section below carefully, federal eligibility categories (nonprofit, state or local government, tribal, individual, educational institution, small business) have distinct registration and reporting requirements. Pre-application outreach to the listed agency contact is permitted and often welcomed, it helps clarify scope and scoring priorities. Before acting on the deadline or award figures above, verify them directly on the official Grants.gov listing, amendments can change dates and amounts after this page was last refreshed.
Award Range
Varies by applicant
Close Date
October 5, 2023
Posted
May 22, 2023
Est. Total Funding
$4,440,000
Expected Awards
5
Instrument
Grant
Description
The NFRP Investigator-Initiated Research Award supports highly rigorous, high-impact research projects that have the potential to make an important contribution to NF research and/or patient care. Research projects may focus on any phase of research, excluding clinical trials. The rationale for a research idea may be derived from laboratory discovery, population-based studies, a clinician’s firsthand knowledge of patients, or anecdotal data. Applications must include preliminary and/or published data that are relevant to NF and the proposed research project.Optional NF Open Science Initiative (NF-OSI): The FY23 NFRP supports the NF-OSI (https://www.synapse.org/#!Synapse:syn17083165/wiki/588662), which is aimed at catalyzing research for NF through early access to data and data sharing within the NF community.• The NF Data Portal (https://nf.synapse.org) is a central component of the NF-OSI and is intended as a format on which to share and explore NF datasets, analysis tools, resources, and publications. It is a public repository of raw data of scientific experiments that allows the re-analysis and confirmation of results by a third party.○ The portal is not the place to share finalized results (these are generally publishable figures and related information), but rather any data point or image derived from experiments.○ NF studies that involve generation of extensive datasets including, but not limited to, gene expression, genomic variants, methylation profiles, drug screening, drug combination screening, cellular physiology, chromatin activity, proteomics, imaging, kinomics, pharmacokinetics/pharmacodynamics, and clinical studies are to utilize the NF Data Portal.○ The portal allows participants to use the repository as their private data storage and selectively release the data to the public after an embargo period. For more information and requirements of participation, please visit https://nf.synapse.org/.• Participants in the NF-OSI will share data following the FAIR (Findable, Accessible, Interoperable, and Reusable) Data Principles for reproducible science found in “The FAIR Guiding Principles for scientific data management and stewardship” (https://www.nature.com/articles/sdata201618). Refer to the Data and Research Resources Sharing Plan document in Attachment 7.• Applications utilizing the NF-OSI option will be eligible to apply for Level 2 funding as described in below and in Section II.D.5, Funding Restrictions.• Applications utilizing the NF-OSI option must demonstrate their commitment to meeting the intent of the initiative in their Data and Research Resources Sharing Plan, including a description of milestones with respect to making the data or research resource(s) available and how they will be accessible after the period of performance expires. See Attachment 7.• Applications utilizing the NF-OSI option must describe how participation in the NF-OSI will advance and/or accelerate research in NF.• Applications funded under the NF-OSI option will need to comply with data submission requirements that meet the intent of the initiative as a condition of continued funding for their project.
Eligibility
Grants.gov lists this opportunity under eligibility category code 99. These codes correspond to applicant types (state/local government, tribal organization, nonprofit, educational institution, individual, small business, etc.) defined in Grants.gov's own eligibility reference. See the current Grants.gov eligibility categories or check the official listing below for this opportunity's exact eligibility statement.
Official Listing on Grants.gov
View full details, application forms, and submission instructions.
Agency Contact
CDMRP Help Desk Phone: 301-682-5507 Email: help@eBRAP.org
Key Dates
Frequently Asked Questions
What is this grant opportunity?
Is this opportunity still open?
How much funding is available?
How do I apply?
More from Dept. of the Army -- USAMRAA
BROAD AGENCY ANNOUNCEMENT (BAA) for Extramural Biomedical and Human Performance Research and Development Department of Defense
DOD Defense Health Agency (DHA) Research & Development FY23-FY27 BROAD AGENCY ANNOUNCEMENT for Extramural Medical Research
Department of Defense HIV/AIDS Prevention Program
Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.
Read our methodology - how this data is sourced, computed, and verified.
Related
| Publisher | PlainGrants |
| Sources | the SAM.gov Assistance Listings and Grants.gov |